In our study, a hypomethylated CpG site annotated to TXNIP showed a faster rate of methylation decline in individuals with T2D compared to NGT individuals, resulting in a larger methylation difference between groups, potentially leading to a higher TXNIP gene expression over time. The gene discussed is TXNIP; the disease is type 2 diabetes mellitus.